Proteoglycans in health and disease: the multiple roles of syndecan shedding

Proteolytic processes in the extracellular matrix are a major influence on cell adhesion, migration, survival, differentiation and proliferation. The syndecan cell‐surface proteoglycans are important mediators of cell spreading on extracellular matrix and respond to growth factors and other biologically active polypeptides. The ectodomain of each syndecan is constitutively shed from many cultured cells, but is accelerated in response to wound healing and diverse pathophysiological events. Ectodomain shedding is an important regulatory mechanism, because it rapidly changes surface receptor dynamics and generates soluble ectodomains that can function as paracrine or autocrine effectors, or competitive inhibitors. It is known that the family of syndecans can be shed by a variety of matrix proteinase, including many metzincins. Shedding is particularly active in proliferating and invasive cells, such as cancer cells, where cell‐surface components are continually released. Here, recent research into the shedding of syndecans and its physiological relevance are assessed.

[1]  P. Stahl,et al.  Syndecan-1 Ectodomain Shedding Is Regulated by the Small GTPase Rab5* , 2008, Journal of Biological Chemistry.

[2]  Michael Elkin,et al.  Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. , 2006, The international journal of biochemistry & cell biology.

[3]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[4]  A. Rapraeger,et al.  Syndecan-1 regulates alphavbeta5 integrin activity in B82L fibroblasts. , 2006, Journal of cell science.

[5]  A. Strongin,et al.  Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.

[6]  A. Purushothaman,et al.  Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma* , 2008, Journal of Biological Chemistry.

[7]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[8]  D. Carey,et al.  Syndecan-4 is a primary-response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[9]  T. Yoshizaki,et al.  Cleavage of Syndecan-1 by Membrane Type Matrix Metalloproteinase-1 Stimulates Cell Migration* , 2003, Journal of Biological Chemistry.

[10]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[11]  M. Jalkanen,et al.  Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain , 1987, The Journal of cell biology.

[12]  J. Woessner,et al.  Heparin-enhanced zymographic detection of matrilysin and collagenases. , 2001, Analytical biochemistry.

[13]  S. Uhlig,et al.  A Disintegrin and Metalloproteinase 17 (ADAM17) Mediates Inflammation-induced Shedding of Syndecan-1 and -4 by Lung Epithelial Cells* , 2009, The Journal of Biological Chemistry.

[14]  William C. Parks,et al.  Matrilysin Shedding of Syndecan-1 Regulates Chemokine Mobilization and Transepithelial Efflux of Neutrophils in Acute Lung Injury , 2002, Cell.

[15]  R. Iozzo,et al.  Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine‐rich proteoglycans , 2010, The FEBS journal.

[16]  Heikki Joensuu,et al.  Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. , 2002, Cancer research.

[17]  J. Fox,et al.  ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. , 2000, Biochemical and biophysical research communications.

[18]  M. Remberger,et al.  Increased levels of syndecan-1 in serum during acute graft-versus-host disease. , 2003, Transplantation.

[19]  R. Sanderson,et al.  Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis , 2010, The FEBS journal.

[20]  S. Nadler,et al.  MMP7 Shedding of Syndecan-1 Facilitates Re-Epithelialization by Affecting α2β1 Integrin Activation , 2009, PloS one.

[21]  J. Woodliff,et al.  Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells , 2000, British journal of haematology.

[22]  F. van Roy,et al.  Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent. , 1996, Journal of cell science.

[23]  Viktoriya D. Nikolova,et al.  Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. , 2009, Carcinogenesis.

[24]  L. Suva,et al.  Heparanase promotes the spontaneous metastasis of myeloma cells to bone. , 2004, Blood.

[25]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[26]  B. de Strooper,et al.  Syndecan 3 Intramembrane Proteolysis Is Presenilin/γ-Secretase-dependent and Modulates Cytosolic Signaling* , 2003, Journal of Biological Chemistry.

[27]  S. Lee,et al.  Syndesmos, a protein that interacts with the cytoplasmic domain of syndecan-4, mediates cell spreading and actin cytoskeletal organization. , 2000, Journal of cell science.

[28]  J. Epstein,et al.  Soluble syndecan-1 promotes growth of myeloma tumors in vivo. , 2002, Blood.

[29]  J. Spring,et al.  Drosophila syndecan: conservation of a cell-surface heparan sulfate proteoglycan. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Angelopoulou,et al.  Serum levels of soluble syndecan-1 in Hodgkin's lymphoma. , 2005, Anticancer research.

[31]  A. Rapraeger,et al.  Syndecan-1 regulates αvβ5 integrin activity in B82L fibroblasts , 2006, Journal of Cell Science.

[32]  A. Purushothaman,et al.  Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. , 2010, Blood.

[33]  Hao Wang,et al.  Syndecans, Heparan Sulfate Proteoglycans, Maintain the Proteolytic Balance of Acute Wound Fluids* , 1998, The Journal of Biological Chemistry.

[34]  J. Couchman,et al.  Syndecans promote integrin-mediated adhesion of mesenchymal cells in two distinct pathways. , 2007, Experimental cell research.

[35]  H. Nagase Activation mechanisms of matrix metalloproteinases. , 1997, Biological chemistry.

[36]  H. van den Berghe,et al.  Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican , 1996, The Journal of cell biology.

[37]  J. Couchman,et al.  Syndecan proteoglycan contributions to cytoskeletal organization and contractility , 2009, Scandinavian journal of medicine & science in sports.

[38]  Masato Kato,et al.  Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2 , 1998, Nature Medicine.

[39]  R. Wynn,et al.  Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. , 1999, Science.

[40]  D. Edwards,et al.  The ADAMTS metalloproteinases. , 2005, The Biochemical journal.

[41]  J. Heino,et al.  Syndecan-1 supports integrin alpha2beta1-mediated adhesion to collagen. , 2008, Experimental cell research.

[42]  M. Hengartner,et al.  Syndecan regulates cell migration and axon guidance in C. elegans , 2005, Development.

[43]  Yeong-Wook Song,et al.  Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis , 2009, Nature Medicine.

[44]  J. Sandy,et al.  ADAMTS4 (Aggrecanase-1) Activation on the Cell Surface Involves C-terminal Cleavage by Glycosylphosphatidyl Inositol-anchored Membrane Type 4-Matrix Metalloproteinase and Binding of the Activated Proteinase to Chondroitin Sulfate and Heparan Sulfate on Syndecan-1* , 2004, Journal of Biological Chemistry.

[45]  A. Waage,et al.  Serum syndecan-1: a new independent prognostic marker in multiple myeloma. , 2000, Blood.

[46]  M. Drayson,et al.  Soluble syndecan‐1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival , 2005, British journal of haematology.

[47]  A. Rapraeger,et al.  The syndecan-1 ectodomain regulates αvβ3 integrin activity in human mammary carcinoma cells , 2004, The Journal of cell biology.

[48]  Israel Vlodavsky,et al.  Heparanase Facilitates Cell Adhesion and Spreading by Clustering of Cell Surface Heparan Sulfate Proteoglycans , 2008, PloS one.

[49]  A. Theocharis,et al.  Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting , 2010, The FEBS journal.

[50]  H. Kitagawa,et al.  Heparan sulphate biosynthesis and disease. , 2008, Journal of biochemistry.

[51]  M. Götte,et al.  Inhibition by the Soluble Syndecan-1 Ectodomains Delays Wound Repair in Mice Overexpressing Syndecan-1* , 2004, Journal of Biological Chemistry.

[52]  M. Iruela-Arispe,et al.  Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion. , 2009, The international journal of biochemistry & cell biology.

[53]  Sheikh Abdul Rahman,et al.  Heparan Sulfate Proteoglycans Are Required for Cellular Binding of the Hepatitis E Virus ORF2 Capsid Protein and for Viral Infection , 2009, Journal of Virology.

[54]  M. Bernfield,et al.  Regulated Shedding of Syndecan-1 and -4 Ectodomains by Thrombin and Growth Factor Receptor Activation* , 1997, The Journal of Biological Chemistry.

[55]  S. Miyakis,et al.  Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease , 2005, Clinical chemistry and laboratory medicine.

[56]  G. Gibson,et al.  Molecular Interactions of MMP-13 C-Terminal Domain with Chondrocyte Proteins , 2010, Connective tissue research.

[57]  M. Salmivirta,et al.  Selective Effects of Sodium Chlorate Treatment on the Sulfation of Heparan Sulfate* , 1999, The Journal of Biological Chemistry.

[58]  Guoying Yu,et al.  Oxidative Stress Alters Syndecan-1 Distribution in Lungs with Pulmonary Fibrosis* , 2009, Journal of Biological Chemistry.

[59]  K. MacKenzie,et al.  Transmembrane domains of the syndecan family of growth factor coreceptors display a hierarchy of homotypic and heterotypic interactions , 2007, Proceedings of the National Academy of Sciences.

[60]  N. Ito,et al.  The Second Dimer Interface of MT1-MMP, the Transmembrane Domain, Is Essential for ProMMP-2 Activation on the Cell Surface* , 2008, Journal of Biological Chemistry.

[61]  G. Pier,et al.  Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence , 2001, Nature.

[62]  G. Murphy,et al.  The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition. , 2008, The Biochemical journal.

[63]  R. Gallo,et al.  Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin. , 1996, The Journal of investigative dermatology.

[64]  Choll W. Kim,et al.  Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. , 1994, Molecular biology of the cell.

[65]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[66]  S. Cho,et al.  Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma. , 2003, European urology.

[67]  A. Schmidt,et al.  Plasmin- and Thrombin-accelerated Shedding of Syndecan-4 Ectodomain Generates Cleavage Sites at Lys114–Arg115 and Lys129–Val130 Bonds* , 2005, Journal of Biological Chemistry.

[68]  J. Couchman Faculty Opinions recommendation of Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. , 2009 .

[69]  H. Nakanishi,et al.  A Novel Function of Syndecan-2, Suppression of Matrix Metalloproteinase-2 Activation, Which Causes Suppression of Metastasis* , 2007, Journal of Biological Chemistry.

[70]  T. Peretz,et al.  Newly Generated Heparanase Knock-Out Mice Unravel Co-Regulation of Heparanase and Matrix Metalloproteinases , 2009, PloS one.

[71]  N. Rocamora,et al.  Ezrin links syndecan-2 to the cytoskeleton. , 2000, Journal of cell science.

[72]  H. P. Sørensen,et al.  Heparan Sulfate Regulates ADAM12 through a Molecular Switch Mechanism* , 2008, Journal of Biological Chemistry.

[73]  J. Guan,et al.  Insulin increases shedding of syndecan-1 in the serum of patients with type 2 diabetes mellitus. , 2009, Diabetes research and clinical practice.

[74]  Bryan A. Millis,et al.  Secreted Neutral Metalloproteases of Bacillus anthracis as Candidate Pathogenic Factors* , 2006, Journal of Biological Chemistry.

[75]  M. Klagsbrun,et al.  Activation of syndecan-1 ectodomain shedding by Staphylococcus aureus alpha-toxin and beta-toxin. , 2004, The Journal of biological chemistry.

[76]  F. Zhan,et al.  High heparanase activity in multiple myeloma is associated with elevated microvessel density. , 2003, Cancer research.

[77]  P. Slocombe,et al.  TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. , 1998, FEBS letters.

[78]  D. Edwards,et al.  The ADAM metalloproteinases , 2008, Molecular Aspects of Medicine.

[79]  M. Laato,et al.  Induced expression of syndecan in healing wounds , 1991, The Journal of cell biology.

[80]  Joseph L Goldstein,et al.  Regulated Intramembrane Proteolysis A Control Mechanism Conserved from Bacteria to Humans , 2000, Cell.

[81]  J. Couchman,et al.  A Conserved NXIP Motif Is Required for Cell Adhesion Properties of the Syndecan-4 Ectodomain* , 2006, Journal of Biological Chemistry.

[82]  M. Götte,et al.  Constitutive and accelerated shedding of murine syndecan-1 is mediated by cleavage of its core protein at a specific juxtamembrane site. , 2005, Biochemistry.

[83]  J. Woessner,et al.  Heparan Sulfate Proteoglycans as Extracellular Docking Molecules for Matrilysin (Matrix Metalloproteinase 7)* , 2000, The Journal of Biological Chemistry.

[84]  J. Couchman Syndecans: proteoglycan regulators of cell-surface microdomains? , 2003, Nature Reviews Molecular Cell Biology.

[85]  J. Quigley,et al.  Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.

[86]  P. Slocombe,et al.  TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3 , 1998 .

[87]  W. Parks,et al.  Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. , 2003, The American journal of pathology.

[88]  R. Fässler,et al.  The Cysteine-Rich Domain of Human Adam 12 Supports Cell Adhesion through Syndecans and Triggers Signaling Events That Lead to β1 Integrin–Dependent Cell Spreading , 2000, The Journal of cell biology.

[89]  V. Trinkaus-Randall,et al.  Localization of integrin and syndecan in vivo in a corneal epithelial abrasion and keratectomy. , 1991, Current eye research.

[90]  A. Rapraeger,et al.  Tyrosine Phosphorylation of Syndecan-1 and -4 Cytoplasmic Domains in Adherent B82 Fibroblasts* , 1998, The Journal of Biological Chemistry.

[91]  M Kashiwagi,et al.  TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)* , 2001, The Journal of Biological Chemistry.

[92]  Y. Yun,et al.  Transmembrane Domain-induced Oligomerization Is Crucial for the Functions of Syndecan-2 and Syndecan-4* , 2005, Journal of Biological Chemistry.

[93]  E. Chaikof,et al.  Oxidized linoleic acid regulates expression and shedding of syndecan-4. , 2005, American journal of physiology. Cell physiology.

[94]  Masato Kato,et al.  Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. , 1995, Molecular biology of the cell.

[95]  K. Brew,et al.  TIMP-3 Binds to Sulfated Glycosaminoglycans of the Extracellular Matrix* , 2000, The Journal of Biological Chemistry.

[96]  M. Dhodapkar,et al.  Syndecan-1 (CD138) Immunoreactivity in Bone Marrow Biopsies of Multiple Myeloma: Shed Syndecan-1 Accumulates in Fibrotic Regions , 2001, Modern Pathology.

[97]  Brian J. Ell,et al.  Syndecan-1 regulates αvβ3 and αvβ5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor , 2009, The Journal of experimental medicine.

[98]  Paul Martin,et al.  Inflammatory cells during wound repair: the good, the bad and the ugly. , 2005, Trends in cell biology.

[99]  A. Bennett,et al.  Streptococcus pneumoniae Sheds Syndecan-1 Ectodomains through ZmpC, a Metalloproteinase Virulence Factor* , 2007, Journal of Biological Chemistry.

[100]  M. Simons,et al.  Regulation of Syndecan-4 Phosphorylation in Vivo * , 1998, The Journal of Biological Chemistry.

[101]  X. Leleu,et al.  Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor , 2004, Leukemia.

[102]  Jeffrey D. Esko,et al.  Heparan sulphate proteoglycans fine-tune mammalian physiology , 2007, Nature.

[103]  Séverine Brulé,et al.  The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9. , 2006, Glycobiology.

[104]  A. Woods,et al.  Syndecan-2 Is Expressed in the Microvasculature of Gliomas and Regulates Angiogenic Processes in Microvascular Endothelial Cells* , 2006, Journal of Biological Chemistry.

[105]  J. Couchman,et al.  Syndecans as receptors and organizers of the extracellular matrix , 2009, Cell and Tissue Research.

[106]  C. Vita,et al.  RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44. , 2004, Glycobiology.

[107]  C. Yeaman,et al.  Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1. , 1996, The Biochemical journal.

[108]  A. Woods,et al.  Serine phosphorylation of syndecan-2 proteoglycan cytoplasmic domain. , 1997, Archives of biochemistry and biophysics.

[109]  Gillian Murphy,et al.  Shedding of Syndecan-1 and -4 Ectodomains Is Regulated by Multiple Signaling Pathways and Mediated by a Timp-3–Sensitive Metalloproteinase , 2000, The Journal of cell biology.

[110]  J. Enghild,et al.  The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3. , 2009, Matrix biology : journal of the International Society for Matrix Biology.

[111]  V. Hascall,et al.  Cell surface heparan sulfate proteoglycans. , 1992, The Journal of biological chemistry.

[112]  M. Stepp,et al.  ORIGINAL RESEARCH – BASIC SCIENCE: Primary dermal fibroblasts derived from sdc‐1 deficient mice migrate faster and have altered αv integrin function , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[113]  S. Munteanu,et al.  Highly sulfated glycosaminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant cultures. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[114]  B. Barlogie,et al.  Elevated levels of shed syndecan‐1 correlate with tumour mass and decreased matrix metalloproteinase‐9 activity in the serum of patients with multiple myeloma , 1997, British journal of haematology.

[115]  L. Devy,et al.  Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model. , 2004, The American journal of pathology.

[116]  Bernd Giese,et al.  Latent MMP-9 is bound to TIMP-1 before secretion , 2007, Biological chemistry.

[117]  M. Klagsbrun,et al.  Activation of Syndecan-1 Ectodomain Shedding by Staphylococcus aureus α-Toxin and β-Toxin* , 2004, Journal of Biological Chemistry.

[118]  M. Humphries,et al.  Synergistic control of cell adhesion by integrins and syndecans , 2007, Nature Reviews Molecular Cell Biology.

[119]  P. Slocombe,et al.  The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3 , 2000, FEBS letters.

[120]  S. Curran,et al.  Matrix Metalloproteinase/Tissue Inhibitors of Matrix Metalloproteinase Phenotype Identifies Poor Prognosis Colorectal Cancers , 2004, Clinical Cancer Research.

[121]  S. Selleck,et al.  The Heparan Sulfate Proteoglycans Dally-like and Syndecan Have Distinct Functions in Axon Guidance and Visual-System Assembly in Drosophila , 2005, Current Biology.

[122]  R. Khokha,et al.  Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. , 1994, The Journal of biological chemistry.

[123]  R. Sanderson,et al.  Identification of an Invasion Regulatory Domain within the Core Protein of Syndecan-1* , 2005, Journal of Biological Chemistry.

[124]  H. Larjava,et al.  Expression of proteoglycans and hyaluronan during wound healing. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[125]  A. Rapraeger,et al.  Syndecans in tumor cell adhesion and signaling , 2004, Reproductive biology and endocrinology : RB&E.

[126]  M. Rouabhia,et al.  Porphyromonas gingivalis lipopolysaccharide induces shedding of syndecan‐1 expressed by gingival epithelial cells , 2005, Journal of cellular physiology.